Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
Disease Models & Mechanisms
|
October 7, 2015
GEMMs as preclinical models for testing pancreatic cancer therapies
Aarthi Gopinathan, Jennifer P Morton, Duncan I Jodrell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 17, 2012
The pancreas cancer microenvironment
Christine Feig, Aarthi Gopinathan, Albrecht Neesse, et al.
Gut
|
December 14, 2011
Cathepsin B promotes the progression of pancreatic ductal adenocarcinoma in mice
Aarthi Gopinathan, Gina M Denicola, Kristopher K Frese, et al.
Science (New York, N.Y.)
|
November 6, 2010
Suppression of antitumor immunity by stromal cells expressing fibroblast activation protein-alpha
Matthew Kraman, Paul J Bambrough, James N Arnold, et al.
Future Oncology (London, England)
|
July 18, 2024
PACIFIC-9: Phase III trial of durvalumab + oleclumab or monalizumab in unresectable stage III non-small-cell lung cancer
Fabrice Barlesi, Byoung Chul Cho, Sarah B Goldberg, et al.
Cancer Cell
|
March 14, 2007
Kras(G12D) and Smad4/Dpc4 haploinsufficiency cooperate to induce mucinous cystic neoplasms and invasive adenocarcinoma of the pancreas
Kamel Izeradjene, Chelsea Combs, Melissa Best, et al.
The Journal of Experimental Medicine
|
February 22, 2012
Gamma secretase inhibition promotes hypoxic necrosis in mouse pancreatic ductal adenocarcinoma
Natalie Cook, Kristopher K Frese, Tashinga E Bapiro, et al.
Cancer Research
|
January 7, 2006
Mist1-KrasG12D knock-in mice develop mixed differentiation metastatic exocrine pancreatic carcinoma and hepatocellular carcinoma
David A Tuveson, Liqin Zhu, Aarthi Gopinathan, et al.
Gut
|
September 9, 2015
MRI with hyperpolarised [1-13C]pyruvate detects advanced pancreatic preneoplasia prior to invasive disease in a mouse model
Eva M Serrao, Mikko I Kettunen, Tiago B Rodrigues, et al.
British Journal of Cancer
|
February 14, 2018
A phase I trial of the γ-secretase inhibitor MK-0752 in combination with gemcitabine in patients with pancreatic ductal adenocarcinoma
Natalie Cook, Bristi Basu, Donna-Michelle Smith, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
Disease Models & Mechanisms
|
October 7, 2015
GEMMs as preclinical models for testing pancreatic cancer therapies
Aarthi Gopinathan, Jennifer P Morton, Duncan I Jodrell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 17, 2012
The pancreas cancer microenvironment
Christine Feig, Aarthi Gopinathan, Albrecht Neesse, et al.
Gut
|
December 14, 2011
Cathepsin B promotes the progression of pancreatic ductal adenocarcinoma in mice
Aarthi Gopinathan, Gina M Denicola, Kristopher K Frese, et al.
Science (New York, N.Y.)
|
November 6, 2010
Suppression of antitumor immunity by stromal cells expressing fibroblast activation protein-alpha
Matthew Kraman, Paul J Bambrough, James N Arnold, et al.
Future Oncology (London, England)
|
July 18, 2024
PACIFIC-9: Phase III trial of durvalumab + oleclumab or monalizumab in unresectable stage III non-small-cell lung cancer
Fabrice Barlesi, Byoung Chul Cho, Sarah B Goldberg, et al.
Cancer Cell
|
March 14, 2007
Kras(G12D) and Smad4/Dpc4 haploinsufficiency cooperate to induce mucinous cystic neoplasms and invasive adenocarcinoma of the pancreas
Kamel Izeradjene, Chelsea Combs, Melissa Best, et al.
The Journal of Experimental Medicine
|
February 22, 2012
Gamma secretase inhibition promotes hypoxic necrosis in mouse pancreatic ductal adenocarcinoma
Natalie Cook, Kristopher K Frese, Tashinga E Bapiro, et al.
Cancer Research
|
January 7, 2006
Mist1-KrasG12D knock-in mice develop mixed differentiation metastatic exocrine pancreatic carcinoma and hepatocellular carcinoma
David A Tuveson, Liqin Zhu, Aarthi Gopinathan, et al.
Gut
|
September 9, 2015
MRI with hyperpolarised [1-13C]pyruvate detects advanced pancreatic preneoplasia prior to invasive disease in a mouse model
Eva M Serrao, Mikko I Kettunen, Tiago B Rodrigues, et al.
British Journal of Cancer
|
February 14, 2018
A phase I trial of the γ-secretase inhibitor MK-0752 in combination with gemcitabine in patients with pancreatic ductal adenocarcinoma
Natalie Cook, Bristi Basu, Donna-Michelle Smith, et al.
Page
of 2